Why is Shukra Pharma. falling/rising?

As of 10-Jul, Shukra Pharmaceuticals Ltd is experiencing a price increase, currently at 19.96, reflecting a change of 0.39 or 1.99% upward. The stock has shown strong performance recently, gaining 48.96% over the last 10 days and outperforming its sector by 2.56% today. Over the past year, it has generated a remarkable return of 110.11%, significantly higher than the market's return of 1.46%. However, despite this impressive growth, the company has faced challenges, including a decline in net sales and profit margins, with net sales dropping by 45.95% and profit after tax decreasing by 49.83% over the last nine months. The stock is also considered expensive, trading at a premium compared to its peers, which may raise concerns among investors.
In the broader market context, Shukra Pharmaceuticals has outperformed the Sensex, which has seen a slight decline of 0.06% over the past week, while the stock itself has surged by 20.31%. This stark contrast highlights the stock's strong momentum in a generally flat market. However, the falling investor participation, as indicated by an 11.81% decrease in delivery volume, suggests that while the stock is currently rising, there may be underlying concerns that could affect its sustainability. Additionally, the absence of domestic mutual fund investment could indicate a lack of confidence in the stock's valuation, despite its recent performance.